Literature DB >> 18650389

Structures of PD-1 with its ligands: sideways and dancing cheek to cheek.

Gordon J Freeman1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18650389      PMCID： PMC2492504          DOI： 10.1073/pnas.0805459105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.

Authors:  C C Stamper; Y Zhang; J F Tobin; D V Erbe; S Ikemizu; S J Davis; M L Stahl; J Seehra; W S Somers; L Mosyak
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

2.  Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.

Authors:  J C Schwartz; X Zhang; A A Fedorov; S G Nathenson; S C Almo
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

Review 3.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

4.  Structure and dimerization of a soluble form of B7-1.

Authors:  S Ikemizu; R J Gilbert; J A Fennelly; A V Collins; K Harlos; E Y Jones; D I Stuart; S J Davis
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

5.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

6.  Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Authors:  Julia A Brown; David M Dorfman; Feng-Rong Ma; Elizabeth L Sullivan; Oliver Munoz; Clive R Wood; Edward A Greenfield; Gordon J Freeman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.

Authors:  Jens M Chemnitz; Richard V Parry; Kim E Nichols; Carl H June; James L Riley
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 8.  B7-H1 pathway and its role in the evasion of tumor immunity.

Authors:  Haidong Dong; Lieping Chen
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

9.  Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb.

Authors:  P S Kern; M K Teng; A Smolyar; J H Liu; J Liu; R E Hussey; R Spoerl; H C Chang; E L Reinherz; J H Wang
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

10.  Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.

Authors:  Eszter Lázár-Molnár; Qingrong Yan; Erhu Cao; Udupi Ramagopal; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-18       Impact factor: 11.205
View more
  26 in total

1.  Costimulatory genes: hotspots of conflict between host defense and autoimmunity.

Authors:  Jennifer C Jones; Gordon J Freeman
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

2.  The effects of PDL-Ig on collagen-induced arthritis.

Authors:  Guohua Wang; Ping Hu; Jing Yang; Guanxin Shen; Xiongwen Wu
Journal:  Rheumatol Int       Date:  2009-12-25       Impact factor: 2.631

Review 3.  The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.

Authors:  Kathleen M Mahoney; Gordon J Freeman; David F McDermott
Journal:  Clin Ther       Date:  2015-03-29       Impact factor: 3.393

Review 4.  Mechanism-based treatment of cancer with immune checkpoint inhibitor therapies.

Authors:  Yara Abdou; Manu Pandey; Maithreyi Sarma; Shrunjal Shah; Jeffrey Baron; Marc S Ernstoff
Journal:  Br J Clin Pharmacol       Date:  2020-05-12       Impact factor: 4.335

5.  The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.

Authors:  Alison M Paterson; Keturah E Brown; Mary E Keir; Vijay K Vanguri; Leonardo V Riella; Anil Chandraker; Mohamed H Sayegh; Bruce R Blazar; Gordon J Freeman; Arlene H Sharpe
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

Review 6.  Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design.

Authors:  Sitanshu S Singh; Seetharama D Jois
Journal:  Adv Protein Chem Struct Biol       Date:  2017-10-06       Impact factor: 3.507

Review 7.  The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity.

Authors:  Suzanne Ostrand-Rosenberg; Lucas A Horn; Samuel T Haile
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

8.  Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1.

Authors:  Krzysztof M Zak; Radoslaw Kitel; Sara Przetocka; Przemyslaw Golik; Katarzyna Guzik; Bogdan Musielak; Alexander Dömling; Grzegorz Dubin; Tad A Holak
Journal:  Structure       Date:  2015-10-22       Impact factor: 5.006

9.  HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.

Authors:  Rémi Planès; Lbachir BenMohamed; Kaoutar Leghmari; Pierre Delobel; Jacques Izopet; Elmostafa Bahraoui
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

10.  PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity.

Authors:  Jacqueline Moebius; Rajan Guha; Mary Peterson; Kaveh Abdi; Jeff Skinner; Shanping Li; Gunjan Arora; Boubacar Traore; Sumati Rajagopalan; Eric O Long; Peter D Crompton
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.